This inventor holds 1 USPTO granted patent. Top assignee: Samchully Pharm. Co.,ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Joong Hwan Lee
Introduction
Joong Hwan Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of new compounds that have potential applications in medicine. His work focuses on creating innovative solutions that can aid in the fight against diseases.
Latest Patents
One of Joong Hwan Lee's most recent patents is related to ethylaziridine derivatives and their preparation methods. This invention introduces new ethylaziridine derivatives of formula (I) and outlines their preparation. The compounds developed through this patent serve as useful synthetic intermediates for the synthesis of HIV protease inhibitors and oligopeptide mimetics. This innovation highlights his commitment to advancing pharmaceutical research and development.
Career Highlights
Joong Hwan Lee is currently employed at Samchully Pharm Co., Ltd., where he continues to work on groundbreaking research. His role at the company allows him to collaborate with other talented professionals in the field. His dedication to innovation has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Joong Hwan Lee has worked alongside esteemed colleagues, including Byung Moon Kim and Sung Jin Bae. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of new technologies.
Conclusion
Joong Hwan Lee's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative work on ethylaziridine derivatives demonstrates his commitment to advancing medical science. As he continues to collaborate with other experts, his impact on the industry is likely to grow even further.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile